Testing the Nephroprotective Effectiveness of Cherry Fruit Extract (Muntingia calabura L.) on Histopathology and Inflammatory Markers in White Rats Induced by Gentamicin
Main Article Content
Page: 1868-1877
Abstract
Background: Kidney disease remains a major global health problem, one of which is associated with the use of nephrotoxic drugs such as gentamicin. Gentamicin induces renal damage through oxidative stress and inflammatory mechanisms. Muntingia calabura L. fruit contains bioactive compounds, including flavonoids and phenolic substances, which are believed to have nephroprotective properties. Objective: This study aimed to evaluate the nephroprotective effectiveness of Muntingia calabura fruit extract on renal histopathological changes and inflammatory markers in gentamicin-induced rats. Methods: This experimental laboratory study employed a post-test only control group design. A total of 25 male white rats were divided into five groups: negative control (0.5% CMC-Na), positive control (gentamicin 80 mg/kg BW), and three treatment groups receiving gentamicin 80 mg/kg BW combined with graded doses of Muntingia calabura fruit extract (50, 100, and 200 mg/kg BW) orally for 7 days. Renal histopathology was examined using hematoxylin-eosin (HE) staining, while serum interleukin-6 (IL-6) levels were measured using enzyme-linked immunosorbent assay (ELISA). Results: Administration of Muntingia calabura fruit extract significantly reduced IL-6 levels and improved renal histopathological features compared to the positive control group (p < 0.05). The nephroprotective effect increased in a dose-dependent manner, with the highest dose (200 mg/kg BW) showing renal conditions closest to normal. Conclusion: Muntingia calabura fruit extract has potential as a natural nephroprotective agent against gentamicin-induced nephrotoxicity through inhibition of inflammatory response as indicated by decreased IL-6 levels.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Bikbov B, Purcell CA, Levey AS, et al. Global burden of chronic kidney disease. Lancet. 2020;395(10225):709–733. doi:10.1016/S0140-6736(20)30045-3. DOI: https://doi.org/10.1016/S0140-6736(19)32977-0
Balakumar P, Rohilla A. Therapeutic targets in gentamicin-induced nephrotoxicity. Eur J Pharmacol. 2023;941:175503. doi:10.1016/j.ejphar.2022.175503.
Cumaoglu MO, Makav M, Dag S, et al. Combating oxidative stress and inflammation in gentamicin-induced nephrotoxicity. Tissue Cell. 2024;91:102604. doi:10.1016/j.tice.2024.102604. DOI: https://doi.org/10.1016/j.tice.2024.102604
El-Shitany NA, et al. Gentamicin-induced nephrotoxicity: role of oxidative stress and inflammation. Biomed Pharmacother. 2023;164:114979. doi:10.1016/j.biopha.2023.114979. DOI: https://doi.org/10.1016/j.biopha.2023.114979
Degirmentepe E, Yilmaz A, Kaya O, Cetin A. Liraglutide attenuates gentamicin-induced nephrotoxicity. J Biochem Mol Toxicol. 2024;38(1):e23456. doi:10.1002/jbt.23456. DOI: https://doi.org/10.22541/au.170667637.73384804/v1
Tan SY, et al. Plant flavonoids on oxidative stress-mediated kidney inflammation. Front Pharmacol. 2022;13:1034821. doi:10.3389/fphar.2022.1034821.
Zhang L, Xu F, Hou L. IL-6 and kidney disease. Front Immunol. 2024;15:1298456. doi:10.3389/fimmu.2024.1298456. DOI: https://doi.org/10.3389/fimmu.2024.1465625
Ali BH, Al Za’abi M, Al Suleimani Y, et al. The role of oxidative stress in gentamicin nephrotoxicity.
Drug Chem Toxicol. 2021;44(4):357–364. doi:10.1080/01480545.2019.1689157.
Tavafi M. Inhibition of inflammatory pathways in gentamicin nephrotoxicity. Iran J Basic Med Sci. 2013;16(7):886–891.
Walker PD, Shah SV. Evidence suggesting a role for TNF-α in gentamicin nephrotoxicity. Kidney Int. 1988;34(5):728–735.
Althunibat OY, et al. Nephroprotective effect of ferulic acid on gentamicin-induced nephrotoxicity. Drug Chem Toxicol. 2020;43(3):292–299. doi:10.1080/01480545.2018.1527757.
El-Sheikh MA, et al. Naringin ameliorates gentamicin-induced nephrotoxicity. Food Chem Toxicol. 2014;62:670–678. doi:10.1016/j.fct.2013.10.036. DOI: https://doi.org/10.1016/j.fct.2013.10.036
Ahmed AS, et al. Taxifolin attenuates gentamicin-induced renal inflammation. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:1123–1134.
Murni HH, Khairi N, Fadri A, et al. Phytochemical and antioxidant activity of Muntingia calabura fruits. J Fac Pharm Ankara Univ. 2024;48(3):903–911.
Puspitasari D, Wulandari R. Antioxidant activity of Muntingia calabura L. extracts. J Herbal Med. 2024;39:100655. doi:10.1016/j.hermed.2023.100655. DOI: https://doi.org/10.1016/j.hermed.2023.100655
Permana R, Sari MI, Putri AR, Nugroho AE. Anti-inflammatory activity of Muntingia calabura. J Ethnopharmacol. 2024;327:117122. doi:10.1016/j.jep.2024.117122.
Lei Z, et al. Role of IL-6 signaling in kidney inflammation. Cytokine. 2023;167:156267.
Tunnur U, et al. Histopathological scoring of gentamicin-induced renal injury. Jurnal Pembelajaran dan Sains. 2023.
Mustafa Oguz M, et al. Experimental models of gentamicin nephrotoxicity. Ren Fail. 2024;46(1):224–233.
Ali SS, et al. Natural antioxidants as nephroprotective agents. Oxid Med Cell Longev. 2021;2021:6629318.